期刊文献+

透皮芦荟苦素纳米粒的制备及其对酪氨酸酶活性的抑制作用 被引量:3

Synthesis of transdermal aloesin loaded zinc oxide nanoparticles and its inhibitory effect on the activity of tyrosinase
原文传递
导出
摘要 采用溶胶-凝胶法制备氧化锌量子点(ZnO QDs),表面用3-氨丙基三乙氧基硅烷(APTES)改性,制备氨基化的ZnO QDs。同时,利用N,N′-羰基二咪唑(CDI)活化芦荟苦素(Alo),与氨基化的ZnO QDs反应,将Alo共价连接在ZnO QDs表面,获得芦荟苦素纳米粒(Alo NPs)。采用透射电子显微镜(TEM)、动态光散射仪(DLS)、傅里叶变换红外光谱仪(FTIR)和热重分析仪(TGA)对Alo NPs的形貌、粒径、结构进行了表征。测试表明,ZnO QDs呈类圆形,由于Alo的连接,原本粒径分布在4 nm左右的粒子粒径增加至8 nm左右。TG结果显示Alo NPs中,ZnO QDs和Alo的质量分数分别为39.27%、35.14%。透皮渗透实验结果表明Alo NPs能显著提高Alo的透皮效率。体外释药行为显示,Alo-NPs在酸性条件下(pH=5.0)2 h即能释放87.63%±0.46%的Alo,而在pH=7.4的介质中,2 h内的累积释放率只有1.45%±0.21%。Alo-NPs对酪氨酸酶活性抑制率呈浓度依赖型,当ZnO QDs的当量溶度为12.5μg/mL时,抑制率可高达40.32%±1.57%。这些结果说明Alo NPs作为外用酪氨酸酶活性抑制剂具有潜在的应用价值。 Zinc oxide quantum dots(ZnO QDs)were synthesized by gel-sol method and employed as the transdermal aloesin(Alo)carriers.ZnO QDs were surface-functionalized with amino using aminopropyltriethoxysilane(APTES).Alo was covalently bonded on the surface of ZnO QDs via N,N'-carbonyldiimidazole to obtain Alo NPs,which were characterized by transmission electron microscope(TEM),dynamic light scattering(DLS),Fourier transform infrared spectroscopy(FTIR)and thermal gravimetric analyzer(TGA).TEM images showed that ZnO QDs were analogously sphere and monodisperse with a reasonably narrow size distribution,of which was around 4 nm.The size of Alo NPs increased to around 8 nm due to the surface modification.The intense bands at around 3 400 cm–1 and 1 200 cm–1 in the FTIR spectrum of Alo NPs from the vibration of-OH indicated the linkage of Alo on the surface of ZnO QDs.The results of TGA analysis showed that the mass ratio of ZnO QDs and Alo were 39.27%and 35.14%,respectively.The penetration of Alo NPs was much higher than raw Alo according to the passive penetration experiments with Franz-type diffusion cells instrument using full-thickness cavy skin,which manifested the improvement of the penetration for Alo delivered by ZnO QDs.The pH-controlled drug release behavior in vitro was investigated.At pH 7.4,only a small amount of Alo(1.45%±0.21%)had been released after 2 h.In contrast,as incubation at pH 5.0 of which pH was similar to endosomal environment,Alo was released very fast(87.63%±0.46%in 2 h)from Alo NPs,confirming that Alo NPs could response to the pH and realize the intracellular drug release.The inhibitory effect of Alo NPs on tyrosinase was in a dose dependent manner.When the concentration of Alo NPs was 12.5μg/mL,the inhibition rate was up to 40.32%±1.57%.All the results show that the Alo NPs hold a great potential in transdermal tyrosinase inhibition.
作者 黄啸 陈春 龚星全 肖祖丽 石秀兰 郑曦 潘玉竹 易彩霞 HUANG Xiao;CHEN Chun;GONG Xingquan;XIAO Zuli;SHI Xiulan;ZHENG Xi;PAN Yuzhu;YI Caixia(School of Sports and Health Science,Tongren University,Tongren,Guizhou 554300,P.R.China;College of Material and Chemical Engineering,Tongren University,Tongren,Guizhou 554300,P.R.China;Chongqing Mix Biotechnology co.,Ltd.,Chongqing 400039,P.R.China)
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2019年第2期254-259,共6页 Journal of Biomedical Engineering
基金 国家自然科学基金项目(31800839 81860324) 贵州省教育厅青年科技人才成长项目(黔教合KY字[2017]311) 国家级大学生创新创业训练计划(201710665002) 铜仁学院大学科技园入园孵化项目(trxykjy2017002) 贵州省基础研究计划项目(黔科合基础[2016]1152) 铜仁市科技计划项目(铜市科研[2018]19号)
关键词 芦荟苦素 氧化锌量子点 酪氨酸酶抑制剂 透皮运输 控制释放 aloesin zinc oxide quantum dots tyrosinase inhibitor transdermal delivery controlled release
  • 相关文献

参考文献1

二级参考文献26

  • 1Nam H Y,Nam K,Lee M,et al.Dendrimer type bio-reducible polymer for efficient gene delivery[J].J Control Release,2012,160(3):592-600.
  • 2Eguchi A,Dowdy S F.siRNA delivery using peptide transduction domains[J].Trends Pharmacol Sci,2009,30(7):341-345.
  • 3Kim T I,Ou M,Lee M,et al.Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems[J].Biomaterials,2009,30(4):658-664.
  • 4Lundberg M,Wikstrm S,Johansson M.Cell surface adherence and endocytosis of protein transduction domains[J].Mol Ther,2003,8(1):143-150.
  • 5Kim S W,Kim N Y,Choi Y B,et al.RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system[J].J Control Release,2010,143(3):335-343.
  • 6Fuchs S M,Raines R T.Pathway for polyarginine entry into mammalian cells[J].Biochemistry,2004,43(9):2438-2444.
  • 7Kunath K,von Harpe A,Fischer D,et al.Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery:comparison of physicochemical properties,transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine[J].J Control Release,2003,89(1):113-125.
  • 8Breunig M,Lungwitz U,Liebl R,et al.Gene delivery with low molecular weight linear polyethylenimines[J].J Gene Med,2005,7(10):1287-1298.
  • 9Reschel T,Koňák Cˇ,Oupick D,et al.Physical properties and in vitro transfection efficiency of gene delivery vectors based on complexes of DNA with synthetic polycations[J].J Control Release,2002,81(1-2):201-217.
  • 10Hashimoto T,Kawazu T,Nagasaki T,et al.Quantitative comparison between poly (L-arginine) and poly (L-lysine) at each step of polyplex-based gene transfection using a microinjection technique[J].Sci Technol Adv Mater,2012,13(1):015009.

共引文献1

同被引文献64

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部